Search Results - "Fauser, A A"

A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation by Baumann, F T, Kraut, L, Schüle, K, Bloch, W, Fauser, A A

“…A haematopoietic SCT (HSCT) can cause severe side effects, which may have a profound impact on a patient's life both physically and psychologically. Some…”
Get full text

Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation by BORNHÄUSER, Martin, OELSCHLAEGEL, Uta, THEUSER, Catrin, MOHR, Brigitte, BRENDEL, Cornelia, FAUSER, Axel A, KLEIN, Stefan, MARTIN, Hans, EHNINGER, Gerhard, THIEDE, Christian, PLATZBECKER, Uwe, BUG, Gesine, LUTTERBECK, Karin, KIEHL, Michael G, SCHETELIG, Johannes, KIANI, Alexander, ILLMER, Thomas, SCHAICH, Markus

“…Analysis of donor chimerism is an important diagnostic tool to assess the risk of relapse after allogeneic stem cell transplantation, especially in patients…”
Get full text

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV by Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S

“…Treatment of chronic myeloid leukemia (CML) has been profoundly improved by the introduction of tyrosine kinase inhibitors (TKIs). Long-term survival with…”
Get full text

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group by BASARA, N, BAURMANN, H, KOLBE, K, YAMAN, A, LABOPIN, M, BURCHARDT, A, HUBER, C, FAUSER, A. A, SCHWERDTFEGER, R

“…A total of 155 patients with acute myeloid leukemia (AML) received hematopoietic stem cell transplants from unrelated donors after standard conditioning…”
Get full text

Cidofovir for BK Virus-Associated Hemorrhagic Cystitis: A Retrospective Study by Cesaro, Simone, Hirsch, Hans H., Faraci, Maura, Owoc-Lempach, Joanna, Beltrame, Angela, Tendas, Andrea, Baltadakis, Ioannis, Dalle, Jean-Hughes, Koc, Yener, Toporski, Jacek, Styczynski, Jan, Yesilipek, M. Akif, Heinz, Werner, Caniglia, Maurizio, Rascon, Jelena, Fauser, Axel A., Michallet, Mauricette, Corral, Lucia Lopez, Neuburger, Stefan, Tridello, Gloria, Einsele, Herman

“…Background.BK virus-associated hemorrhagic cystitis (BKV-HC) is a severe complication after allogeneic hematopoietic stem cell transplantation (HSCT), but…”
Get full text

Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention by Baumann, Freerk T., Zopf, Eva M., Nykamp, Eike, Kraut, Ludwig, Schüle, Klaus, Elter, Thomas, Fauser, Axel A., Bloch, Wilhelm

“…An allogeneic hematopoietic stem cell transplantation (HSCT) can have profound and lasting adverse effects on a patient’s physical and psychological…”
Get full text

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia by Craddock, C, Labopin, M, Pillai, S, Finke, J, Bunjes, D, Greinix, H, Ehninger, G, Steckel, N-K, Zander, A R, Schwerdtfeger, R, Buchholz, S, Kolb, H-J, Volin, L, Fauser, A, Polge, E, Schmid, C, Mohty, M, Rocha, V

“…Treatment options for adults with primary refractory acute myeloid leukaemia (PREF AML) are extremely limited. Although sibling allogeneic stem cell…”
Get full text

Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group by SCHETELIG, J, THIEDE, C, HELD, T. K, HÖFFKEN, K, HO, A. D, KIENAST, J, NEUBAUER, A, ZANDER, A. R, FAUSER, A. A, EHNINGER, G, SIEGERT, W, BORNHÄUSER, M, SCHWERDTFEGER, R, KIEHL, M, BEYER, J, SAYER, H. G, KRÖGER, N, HENSEL, M, SCHEFFOLD, C

“…To study whether hematopoietic stem-cell transplantation (HSCT) after reduced-intensity conditioning is effective and tolerable in patients with advanced…”
Get full text

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT) by AOUDJHANE, M, LABOPIN, M, SHOUTEN, H, BLAISE, D, FALDA, M, FAUSER, A. A, ESTEVE, J, POLGE, E, SLAVIN, S, NIEDERWIESER, D, NAGLER, A, ROCHA, V, GORIN, N. C, SHIMONI, A, RUUTU, T, KOLB, H.-J, FRASSONI, F, BOIRON, J. M, YIN, J. L, FINKE, J

“…Results of reduced intensity conditioning regimen (RIC) in the HLA identical haematopoietic stem cell transplantation (HSCT) setting have not been compared to…”
Get full text

A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) by AL-ALI, H. K, BRAND, R, NIEDERWIESER, D, DE WITTE, T, VAN BIEZEN, A, FINKE, J, BOOGAERTS, M, FAUSER, A. A, EGELER, M, CAHN, J.-Y, ARNOLD, R, BIERSACK, H

“…Hematopoietic cell transplantation (HCT) is an effective treatment for myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML). In this study, outcome…”
Get full text

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation by Mohty, Mohamad, Labopin, Myriam, Tabrizzi, Reza, Theorin, Niklas, Fauser, Axel A, Rambaldi, Alessandro, Maertens, Johan, Slavin, Shimon, Majolino, Ignazio, Nagler, Arnon, Blaise, Didier, Rocha, Vanderson, on behalf of Acute Leukemia Working Party

“…1 Service d’Hématologie Clinique, CHU Hôtel Dieu, Université de Nantes, Nantes, France; 2 European Group for Blood and Marrow Transplantation (EBMT), Acute…”
Get full text

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission by KIEHL, Michael G, KRAUT, Ludwig, GANSER, Arnold, ZANDER, Axel R, KIENAST, Joachim, EHNINGER, Gerhard, HOELZER, Dieter, DIEHL, Volker, FAUSER, Axel A, RINGDEN, Olle, SCHWERDTFEGER, Rainer, HERTENSTEIN, Bernd, REMBERGER, Mats, KROEGER, Nicolaus, STELLJES, Mathias, BORNHAEUSER, Martin, MARTIN, Harts, SCHEID, Christoph

“…The role of unrelated allogeneic stem-cell transplantation in acute lymphoblastic leukemia (ALL) patients is still not clear, and only limited data are…”
Get full text

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications by BEELEN, D. W, TRENSCHEL, R, BAUMGART, J, PICHLMEIER, U, HAHN, J. R, HOLLER, E, CASPER, J, FREUND, M, HILGER, R. A, SCHEULEN, M. E, BASARA, N, FAUSER, A. A, HERTENSTEIN, B, MYLIUS, H. A

“…Treosulphan has recently demonstrated antileukaemic activity and potent haematopoietic stem cell toxicity. Dose-escalated treosulphan (3 x 12 or 3 x 14 g/m2)…”
Get full text

Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab by Willenbacher, Wolfgang, Basara, Nadesta, Blau, Igor W., Fauser, Axel A., Kiehl, Michael G.

“…Competitive inhibition of interleukin 2‐dependent lymphocytes by daclizumab demonstrates some beneficial effects in the treatment of graft‐versus‐host disease…”
Get full text

Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience by Roemer, E., Blau, I. W., Basara, N., Kiehl, M. G., Bischoff, M., Günzelmann, S., Kirsten, D., Sanchez, H., Wocker, E. L., Fauser, A. A.

“…Toxoplasmosis is a rare but often fatal complication that occurs after patients undergo allogeneic hematopoietic stem cell transplant. At our institution,…”
Get full text

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease by ARNOLD, R, MASSENKEIL, G, KOLB, H. J, KOLBE, K, SAYER, H. G, SCHWERDTFEGER, R, WANDT, H, HOELZER, D, BORNHÄUSER, M, EHNINGER, G, BEELEN, D. W, FAUSER, A. A, HEGENBART, U, HERTENSTEIN, B, HO, A. D, KNAUF, W

“…The feasibility of nonmyeloablative stem cell transplantation (NST) was evaluated in 22 adults with high-risk ALL. 16/22 patients had advanced disease and…”
Get full text

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients by BASARA, N, BLAU, W. I, RÖMER, E, RUDOLPHI, M, BISCHOFF, M, KIRSTEN, D, SANCHEZ, H, GÜNZELMANN, S, FAUSER, A. A

“…The efficacy and safety of mycophenolate mofetil (MMF) in combination with CsA and prednisolone for the treatment of acute and chronic GVHD (aGVHD and cGVHD,…”
Get full text

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors by Remberger, Mats, Ringdén, Oolle, Blau, Igor-Wolfgang, Ottinger, Hellmut, Kremens, Bernhard, Kiehl, Micheil G., Aschan, Johan, Beelen, Dietrich W., Basara, Nadezda, Kumlien, Gunilla, Fauser, Axel A., Runde, Volker

“…The clinical results in 107 patients receiving a peripheral blood stem cell (PBSC) graft mobilized by granulocyte colony-stimulating factor (G-CSF) from HLA-A,…”
Get full text

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia by Stelljes, Matthias, Bornhauser, Martin, Kroger, Matthias, Beyer, Joerg, Sauerland, Maria C., Heinecke, Achim, Berning, Bjorna, Scheffold, Christian, Silling, Gerda, Buchner, Thomas, Neubauer, Andreas, Fauser, Axel A., Ehninger, Gerhard, Berdel, Wolfgang E., Kienast, Joachim

“…Seventy-one patients with acute myeloid leukemia (AML), most of them (63/71) considered ineligible for conventional allogeneic hematopoietic stem cell…”
Get full text

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor by SAYER, H. G, KRÖGER, M, MARTIN, H, SCHETELIG, J, BEELEN, D. W, FAUSER, A, KIENAST, J, HÖFFKEN, K, EHNINGER, G, BORNHÄUSER, M, BEYER, J, KIEHL, M, KLEIN, S. A, SCHAEFER-ECKART, K, SCHWERDTFEGER, R, SIEGERT, W, RUNDE, V, THEUSER, C

“…We analyzed predictive factors for the outcome of 113 acute myeloid leukemia patients receiving reduced-intensity conditioning prior to allogeneic…”
Get full text